Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
102
days
Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics
Authors
Claire Brillac; Dorothée Sémiond; Corina Oprea; André Baruchel; C. Michel Zwaan; Laurent NguyenShow moreShow less
Affiliations
1. Sanofi Research and Development, Vitry-sur-Seine, France; 2. Sanofi, Cambridge, MA, USA; 3. Robert Debré University Hospital (APHP and Université Paris Cité), Paris, France; 4. Princess Máxima Centre for Pediatric Oncology, Utrecht, The Netherlands, and Department of Pediatric Oncology, Erasmus MC - Sophia Children’s Hospital, Rotterdam, The NetherlandsShow moreShow less
107
days
Mechanisms of resistance to antibody-drug conjugates in cancer: molecular barriers and pharmacological solutions
Authors
Lina Eltaib; Muhammad Afzal; Chandana Maji; H. Malathi; Kavita Goyal; Haider Ali; Gaurav Gupta; Md Sadique HussainShow moreShow less
Affiliations
1. Department of Pharmaceutics, College of Pharmacy, Northern Border University, Rafha, Saudi Arabia; 2. Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah, Saudi Arabia; 3. Noida Institute of Engineering and Technology (Pharmacy Institute), Greater, India; 4. Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, India; 5. Department of Biotechnology, Graphic Era (Deemed to be University), Clement Town, Dehradun, India; 6. Centre for Global Health Research, Saveetha Institute of Medical and Technical Sciences, Saveetha Medical College, Saveetha University, Chennai, India; 7. Centre for Research Impact & Outcome-Chitkara College of Pharmacy, Chitkara University, Rajpura, India; 8. Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, UAE; 9. Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; 10. School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, IndiaShow moreShow less
132
days
Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer
Authors
Martina Catalano; Gestiana Cekrezi; Irene De Gennaro Aquino; Delia Ravizza; Alexandra Paulet; Kristian Shtembari; Claudia De Angelis; Roberto Petrioli; Daniele Generali; Giandomenico RovielloShow moreShow less
Affiliations
1. Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy; 2. School of Medicine and Surgery, University of Florence, Florence, Italy; 3. Clinical Oncology, Careggi University Hospital, Florence, Italy; 4. Medical Oncology Unit, Careggi University Hospital, Florence, Italy; 5. Unit of Medical Oncology, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy; 6. Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy; 7. Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, Cremona, ItalyShow moreShow less
152
days
6-gingerol alleviates chemotherapy-induced nausea and vomiting by inhibiting ferroptosis via the regulation of iron homeostasis
Authors
Wan Liang; Lei Feng; Siyu Han; Chenglu Yang; Binbin Ye; Ziyao Mo; Ke NieShow moreShow less
Affiliations
1. School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, P.R. ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days